Inadequate Monitoring Inadequate monitoring places patients in danger
Effectiveness: Metformin can cause some weight loss, although not as much as the GLP-1 drugs
The FDA's MedWatch database had received more than 100 adverse event reports linked to compounded semaglutide as of late 2024, including cases of hypoglycemia, severe nausea requiring hospitalization, and one confirmed death under investigation
BPC 157 is a peptide, not a steroid
Unlike direct growth hormone supplementation, it stimulates the pituitary gland to produce its own GH, working with the body's regulatory mechanisms rather than bypassing them
"In the U.S., because there are no legal standards for the 'GLP-1 Friendly' phrase, most high-protein and high-fiber products carry the label," a food industry official said